Vanda Pharmaceuticals (VNDA) Asset Utilization Ratio (2011 - 2026)
Vanda Pharmaceuticals (VNDA) posted Asset Utilization Ratio of 0.47 for Q1 2026, up 19.09% sequentially from 0.4 in Q4 2025, and up 51.03% YoY from 0.31 in Q1 2025.
Vanda Pharmaceuticals (VNDA) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
Vanda Pharmaceuticals has reported Asset Utilization Ratio for 16 years, with the latest figure at 0.47 in Q1 2026.
- Quarterly Asset Utilization Ratio rose 51.03% year-over-year to 0.47 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.47 (up 51.03% YoY) and the FY2025 annual result came in at 0.38, up 23.86% from the prior year.
- Asset Utilization Ratio climbed to 0.47 in Q1 2026 per VNDA's latest filing, from 0.4 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.47 in Q1 2026 and troughed at 0.27 in Q1 2024.
- A 5-year average of 0.36 and a median of 0.35 in 2025 frame the typical range for Asset Utilization Ratio.
- The sharpest annual moves came in 2024 and 2026: Asset Utilization Ratio tumbled 32.0% in 2024, then jumped 51.03% in 2026.
- Over 5 years, Asset Utilization Ratio stood at 0.41 in 2022, then declined by 26.27% to 0.3 in 2023, then increased by 2.29% to 0.31 in 2024, then gained by 29.79% to 0.4 in 2025, then grew by 19.09% to 0.47 in 2026.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.47, 0.4, and 0.35 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.69 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 186.67 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.13 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.90 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.54 |
| 10 | Vanda Pharmaceuticals | 315.57 Mn | 145.54 Mn | 46.97 Mn | 0.51 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.51 |
| Mar 31, 2026 | 0.47 |
| Dec 31, 2025 | 0.40 |
| Sep 30, 2025 | 0.35 |
| Jun 30, 2025 | 0.32 |
| Mar 31, 2025 | 0.31 |
| Dec 31, 2024 | 0.31 |
| Sep 30, 2024 | 0.29 |
| Jun 30, 2024 | 0.28 |
| Mar 31, 2024 | 0.27 |
| Dec 31, 2023 | 0.30 |
| Sep 30, 2023 | 0.33 |
| Jun 30, 2023 | 0.37 |
| Mar 31, 2023 | 0.40 |
| Dec 31, 2022 | 0.41 |
| Sep 30, 2022 | 0.42 |
| Jun 30, 2022 | 0.43 |
| Mar 31, 2022 | 0.44 |
| Dec 31, 2021 | 0.46 |
| Sep 30, 2021 | 0.47 |